American Journal of Cardiology
Volume 102, Issue 6 , Pages 683-688 , 15 September 2008

Incidence of Coronary Stent Thrombosis Based on Academic Research Consortium Definitions

Received 7 December 2007 ,Revised 23 April 2008 ,Accepted 23 April 2008.

References 

  1. Moses JW, Leon MB, Popma JJ, Fitzgerald PJ, Holmes DR, O'Shaughnessy C, et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med. 2003;349:1315–1323
  2. Stone GW, Ellis SG, Cox DA, Hermiller J, O'Shaughnessy C, Mann JT, et al. One-year clinical results with the slow-release, polymer-based, paclitaxel-eluting TAXUS stent: the TAXUS-IV Trial. Circulation. 2004;109:1942–1947
  3. Pfisterer M, Brunner-La Rocca HP, Buser PT, Rickenbacher P, Hunziker P, Mueller C, et al. Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting versus bare-metal stents. J Am Coll Cardiol. 2006;48:2584–2591
  4. Bavry AA, Kumbhani DJ, Helton TJ, Borek PP, Mood GR, Bhatt DL. Late thrombosis of drug-eluting stents: a meta-analysis of randomized clinical trials. Am J Med. 2006;119:1056–1061
  5. Lagerqvist B, James SK, Stenestrand U, Lindback J, Nilsson T, Wallentin L SCAAR Study Group. Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden. N Engl J Med. 2007;356:1009–1019
  6. Mauri L, Hsieh WH, Massaro JM, Ho KKL, D'Agostino R, Cutlip DE. Stent thrombosis in randomized clinical trials of drug-eluting stents. N Engl J Med. 2007;356:1020–1029
  7. Applegate RJ, Sacrinty MT, Kutcher MA, Baki TT, Gandhi SK, Santos RM, et al. Comparison of drug-eluting versus bare metal stents on later frequency of acute myocardial infarction and death. Am J Cardiol. 2007;99:333–338
  8. Applegate RJ, Sacrinty MT, Kutcher MA, Santos RM, Gandhi SK, Baki TT, et al “Off-label” stent therapy—2 year comparison of drug-eluting versus bare metal stents. J Am Coll Cardiol. 2008;51:607–614
  9. American College of Cardiology. National Cardiovascular Data Registry Module Version 3.0. 2004. http://www.accncdr.com/webNCDR/NCDRDocuments/datadictdefsonlyv30.pdfAccessed October 1, 2007
  10. Eisenstein EL, Anstrom KJ, Kong DF, Shaw LK, Tuttle RH, Mark DB, et al Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation. JAMA. 2007;297:159–168
  11. Hodgson JM, Stone GW, Lincoff AM, Klein L, Walpole H, Bottner R, et al. Late stent thrombosis: considerations and practical advice for the use of drug-eluting stents: a report from the Society for Cardiovascular Angiography and Interventions Drug-Eluting Stent Task Force. Cathet Cardiovasc Intervent. 2007;69:327–333
  12. Hearne SE, Amsterdam PB, Baker WA, Sawchak SR, Phillips HR, Sketch MH, et al. Diagnosing coronary arterial stent thrombosis and arterial closure. Am J Cardiol. 1998;82:666–668
  13. Haude M, Erbel R, Issa H, Straub U, Rupprecht HJ, Treese N, et al. Subacute thrombotic complications after intracoronary implantation of Palmaz-Schatz stents. Am Heart J. 1993;126:15–22
  14. Little WC, Constantinescu M, Applegate RJ, Kutcher MA, Burrows MT, Kahl FR, et al. Can coronary angiography predict the site of a subsequent myocardial infarction in patients with mild to moderate coronary artery disease?. Circulation. 1988;78:1157–1166

PII: S0002-9149(08)00840-0

doi: 10.1016/j.amjcard.2008.04.050

American Journal of Cardiology
Volume 102, Issue 6 , Pages 683-688 , 15 September 2008

Article Tools

* Image Usage & Resolution